Valantine Hannah (CIK 1855608) reported 27 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-24). Recent activity: Buy BBIO (3,990 shares), Buy BBIO (2,808 shares), Sell BBIO (2,808 shares), Sell BBIO (2,196 shares), Buy CDNA (9,795 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-24 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 3,990 | $0 |
| 2026-06-24 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 2,808 | $117,178 |
| 2026-06-24 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 2,808 | $190,944 |
| 2026-06-24 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 2,196 | $150,580 |
| 2026-06-16 | CareDx, Inc. (CDNA) | Director | Buy | 9,795 | $0 |
| 2026-06-16 | CareDx, Inc. (CDNA) | Director | Sell | 12,103 | $279,728 |
| 2026-03-12 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 8,671 | $237,239 |
| 2026-03-12 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 8,671 | $624,312 |
| 2026-03-03 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 25,484 | $1.2M |
| 2026-03-03 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 14,584 | $978,295 |
| 2026-03-03 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 10,900 | $739,456 |
| 2025-11-14 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 25,484 | $1.7M |
| 2025-11-14 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 25,484 | $1.2M |
| 2025-06-30 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 1,542 | $19,553 |
| 2025-06-30 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 796 | $10,475 |
| 2025-06-30 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 876 | $38,640 |
| 2025-06-30 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 1,542 | $67,863 |
| 2025-06-30 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 398 | $17,564 |
| 2025-06-30 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 1,891 | $83,261 |
| 2025-06-30 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 1,752 | $24,948 |
| 2025-06-24 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 6,589 | $0 |
| 2025-06-23 | CareDx, Inc. (CDNA) | Director | Sell | 10,570 | $202,521 |
| 2025-06-17 | CareDx, Inc. (CDNA) | Director | Buy | 12,103 | $0 |
| 2025-06-11 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 4,292 | $71,891 |
| 2025-06-11 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 4,292 | $171,680 |
Source: SEC Form 4 filings · as of 2026-06-24